By Dr Sarah Larney

Books

Winsley NC; Zador D; Larney S; Dolan K, 2016, Patient motivations, perceptions and experiences of opioid substitution therapy in prison, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Technical%20Report%20Number%20332.pdf

Degenhardt LJ; Gibson G; Leung J; Kumvaj M; Larney S, 2016, Searching the grey literature to access research on illicit drug use, HIV and viral hepatitis A resource to identify drug-related databases and websites, National Drug and Alcohol Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/resource/searching-grey-literature-access-research-illicit-drug-use-hiv-and-viral-hepatitis-resource

Larney S; Toson B; Burns LA; Dolan K, 2011, Opioid substitution treatment in prison and post-release: Effects on criminal recidivism and mortality, National Drug Law Enforcement Research Fund (NDLERF), Canberra, ACT, http://www.ndlerf.gov.au/pub/Monograph_37.pdf

Larney S; Dolan K, 2008, Demand reduction strategies in closed settings in China, Indonesia and Viet Nam, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia

Larney S; Morton P; Dolan K, 2007, Hiv Prevention, Treatment And Care In Prisons In South-East Asia, National Drug and Alcohol Research Centre, University of New, Sydney, NSW, Sydney, http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR+288-292/$file/TR290_TOC_ABSTRACT.pdf

Larney S; Matthers B; Dolan K, 2007, Illicit drug treatment in prison: Detoxification, drug-free units, therapeutic communities and opioid substitution treatment, National Drug & Alcohol Research Centre, Randwick, NSW

Journal articles

Mitra S; Bouck Z; Larney S; Zolopa C; Høj S; Minoyan N; Upham K; Rammohan I; Mok WY; Hayashi K; Milloy MJ; DeBeck K; Scheim A; Werb D, 2024, 'The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis', Harm Reduction Journal, 21, http://dx.doi.org/10.1186/s12954-024-00996-x

Makarenko I; Minoyan N; Bordier Høj S; Udhesister S; Martel-Laferrière V; Jutras-Aswad D; Larney S; Bruneau J, 2024, 'Determinants of psychological distress during the COVID-19 pandemic among people who use drugs in Montreal, Canada', Drug and Alcohol Review, 43, pp. 2077 - 2088, http://dx.doi.org/10.1111/dar.13862

Sutherland R; Gisev N; Larney S, 2024, 'Trends in substance use and related harms among older adults in high-income countries', Addiction, 119, pp. 1676 - 1678, http://dx.doi.org/10.1111/add.16469

Do U; Perron PA; Bruneau J; Larney S, 2024, 'Trends in toxicological findings in unintentional opioid or stimulant toxicity deaths in Québec, Canada, 2012–2021: Has Québec entered a new era of drug-related deaths?', Drug and Alcohol Review, 43, pp. 1613 - 1624, http://dx.doi.org/10.1111/dar.13918

Levinsson A; Zolopa C; Vakili F; Udhesister S; Kronfli N; Maheu-Giroux M; Bruneau J; Valerio H; Bajis S; Read P; Martró E; Boucher L; Morris L; Grebely J; Artenie A; Stone J; Vickerman P; Larney S, 2024, 'Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis', eClinicalMedicine, 72, http://dx.doi.org/10.1016/j.eclinm.2024.102596

Borschmann R; Keen C; Spittal MJ; Preen D; Pirkis J; Larney S; Rosen DL; Møller L; O'Moore E; Young JT; Altice FL; Andrews JR; Binswanger IA; Bukten A; Butler T; Chang Z; Chen CY; Clausen T; Christensen PB; Culbert GJ; Cunningham R; Degenhardt L; Dolan K; Fazel S; Fischbacher C; Giles M; Graham L; Huang YF; Huber F; Karaminia A; King P; Kouyoumdjian FG; Lim S; Liu YE; Lopez D; Moniruzzaman A; Morenoff J; Pizzicato LN; Proescholdbell SK; Ranapurwala SI; Shaw J; Slaunwhite A; Somers JM; Spaulding AC; Stavseth MR; Stern MF; Telfer K; Viner K; Wang N; Zhao B; Zhu N; Kinner SA, 2024, 'Rates and causes of death after release from incarceration among 1 471 526 people in eight high-income and middle-income countries: an individual participant data meta-analysis', The Lancet, 403, pp. 1779 - 1788, http://dx.doi.org/10.1016/S0140-6736(24)00344-1

Price O; Dietze P; Maher L; Dore GJ; Sutherland R; Salom C; Bruno R; Crawford S; Degenhardt L; Larney S; Peacock A, 2024, 'High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs', Vaccine, 42, pp. 2877 - 2885, http://dx.doi.org/10.1016/j.vaccine.2024.03.051

Gibbs D; Colledge-Frisby S; Farnbach S; Doyle M; Shakeshaft A; Larney S, 2024, 'Associations Between Supported Accommodation and Health and Re-offending Outcomes: a Retrospective Data Linkage Study', Journal of Urban Health, 101, pp. 80 - 91, http://dx.doi.org/10.1007/s11524-023-00824-w

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Buizen L; Degenhardt L, 2024, 'Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104287

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Buizen L; Degenhardt L, 2024, 'Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence', Drug and Alcohol Dependence, 260, pp. 110845 - 110845, http://dx.doi.org/10.1016/j.drugalcdep.2023.110845

Gibbs D; Stockings E; Larney S; Bromberg DJ; Shakeshaft A; Farnbach S, 2023, 'The impact of supported accommodation on health and criminal justice outcomes of people released from prison: a systematic literature review', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00832-8

Høj SB; Minoyan N; Zang G; Larney S; Bruneau J, 2023, 'Gender, sexual orientation identity, and initiation of amphetamine injecting among people who inject drugs: Examination of an expanding drug era in Montreal, Canada, 2011–19', Drug and Alcohol Dependence, 251, http://dx.doi.org/10.1016/j.drugalcdep.2023.110956

Downing BC; Hickman M; Jones NR; Larney S; Sweeting MJ; Xu Y; Farrell M; Degenhardt L; Jones HE, 2023, 'Prevalence of opioid dependence in New South Wales, Australia, 2014–16: Indirect estimation from multiple data sources using a Bayesian approach', Addiction, 118, pp. 1994 - 2006, http://dx.doi.org/10.1111/add.16268

Leung J; Chiu V; Man N; Yuen WS; Dobbins T; Dunlop A; Gisev N; Hall W; Larney S; Pearson SA; Degenhardt L; Peacock A; Peacock A, 2023, 'All-cause and cause-specific mortality in individuals with an alcohol-related emergency or hospital inpatient presentation: A retrospective data linkage cohort study', Addiction, 118, pp. 1751 - 1762, http://dx.doi.org/10.1111/add.16218

Gisev N; Buizen L; Hopkins RE; Schaffer AL; Daniels B; Bharat C; Dobbins T; Larney S; Blyth F; Currow DC; Wilson A; Pearson SA; Degenhardt L, 2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159, http://dx.doi.org/10.1001/jamanetworkopen.2023.28159

Larney S; Jones NR; Hickman M; Nielsen S; Ali R; Degenhardt L, 2023, 'Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002–17', Addiction, 118, pp. 1527 - 1539, http://dx.doi.org/10.1111/add.16178

Gisev N; Pearson SA; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow DC; Mattick RP; Degenhardt L, 2023, 'Cohort profile: POPPY II - A population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-068310

Marshall AD; Martinello M; Zolopa C; Treloar C; Larney S, 2023, 'Universal hepatitis C virus screening and treatment as part of prenatal care', The Lancet Gastroenterology and Hepatology, 8, pp. 295 - 297, http://dx.doi.org/10.1016/S2468-1253(22)00421-6

Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A, 2023, 'Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis', Drug and Alcohol Review, 42, pp. 569 - 581, http://dx.doi.org/10.1111/dar.13595

Jiang N; Bruneau J; Makarenko I; Minoyan N; Zang G; Høj SB; Larney S; Martel-Laferrière V, 2023, 'HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers', International Journal of Drug Policy, 113, http://dx.doi.org/10.1016/j.drugpo.2023.103954

Minoyan N; Høj SB; Jutras-Aswad D; Larney S; Martel-Laferrière V; Sylvestre MP; Bruneau J, 2023, 'Binge Drug Injection in a Cohort of People Who Inject Drugs in Montreal: Characterizing the Substances and Social Contexts Involved', International Journal of Mental Health and Addiction, http://dx.doi.org/10.1007/s11469-023-01207-7

Borschmann R; Keen C; Spittal M; Pirkis J; Preen D; Rosen D; Larney S; Young J; Kinner S, 2023, 'High risk of death from multiple causes following release from incarceration: an individual participant data meta-analysis of 1,471526 adults in eight countries', Population Medicine, 5, pp. 521 - 521, http://dx.doi.org/10.18332/popmed/165135

Martin NK; Beletsky L; Linas BP; Bayoumi A; Pollack H; Larney S, 2023, 'Modeling as Visioning: Exploring the Impact of Criminal Justice Reform on Health of Populations with Substance Use Disorders.', MDM Policy Pract, 8, pp. 23814683231202984, http://dx.doi.org/10.1177/23814683231202984

Zolopa C; Brothers TD; Leclerc P; Mary JF; Morissette C; Bruneau J; Hyshka E; Martin NK; Larney S, 2022, 'Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103894

Minoyan N; Høj SB; Zolopa C; Vlad D; Bruneau J; Larney S, 2022, 'Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00620-w

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'Trends in opioid analgesic utilisation among people with a history of opioid dependence', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109548

Jones N; Degenhardt L; Hickman M; Nielsen S; Larney S; Dobbins T; Ali R, 2022, 'The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/ijpds.v7i3.1787

Zolopa C; Høj SB; Minoyan N; Bruneau J; Makarenko I; Larney S, 2022, 'Ageing and older people who use illicit opioids, cocaine or methamphetamine: a scoping review and literature map', Addiction, 117, pp. 2168 - 2188, http://dx.doi.org/10.1111/add.15813

Vo AT; Patton T; Peacock A; Larney S; Borquez A, 2022, 'Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times', International Journal of Environmental Research and Public Health, 19, http://dx.doi.org/10.3390/ijerph19148883

Jones NR; Hickman M; Nielsen S; Larney S; Dobbins T; Ali R; Degenhardt L, 2022, 'The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001–2018: Findings from the OATS retrospective linkage study', Drug and Alcohol Dependence, 236, http://dx.doi.org/10.1016/j.drugalcdep.2022.109464

Colledge-Frisby S; Jones N; Larney S; Peacock A; Lewer D; Brothers TD; Hickman M; Farrell M; Degenhardt L, 2022, 'The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study', Drug and Alcohol Dependence, 236, http://dx.doi.org/10.1016/j.drugalcdep.2022.109494

Zolopa C; Burack JA; O’Connor RM; Corran C; Lai J; Bomfim E; DeGrace S; Dumont J; Larney S; Wendt DC, 2022, 'Changes in Youth Mental Health, Psychological Wellbeing, and Substance Use During the COVID-19 Pandemic: A Rapid Review', Adolescent Research Review, 7, pp. 161 - 177, http://dx.doi.org/10.1007/s40894-022-00185-6

Vuong T; Gillies M; Larney S; Montebello M; Ritter A, 2022, 'The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalizations: a Bayesian analysis of treated patients and matched controls', Addiction, 117, pp. 1589 - 1597, http://dx.doi.org/10.1111/add.15755

Larney S; Madden A; Marshall AD; Martin NK; Treloar C, 2022, 'A gender lens is needed in hepatitis C elimination research', International Journal of Drug Policy, 103, http://dx.doi.org/10.1016/j.drugpo.2022.103654

Chaillon A; Bharat C; Stone J; Jones N; Degenhardt L; Larney S; Farrell M; Vickerman P; Hickman M; Martin NK; Bórquez A, 2022, 'Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia', Addiction, 117, pp. 1338 - 1352, http://dx.doi.org/10.1111/add.15736

Warfield SC; Bharat C; Bossarte RM; DePhilippis D; Farrell M; Hoover M; Larney S; Marshalek P; McKetin R; Degenhardt L, 2022, 'Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109310

Tse WC; Djordjevic F; Borja V; Picco L; Lam T; Olsen A; Larney S; Dietze P; Nielsen S, 2022, 'Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103513

Curtis M; Berk J; Larney S; Rich JD; Stoové M, 2022, 'Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103572

Nielsen S; Larney S, 2022, 'Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment?', Addiction, http://dx.doi.org/10.1111/add.16032

Gibbs D; Grebely J; Sutherland R; Larney S; Butler K; Dietze PM; Starr M; Peacock A, 2021, 'Concordance between self-reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia', Drug and Alcohol Review, 40, pp. 1349 - 1353, http://dx.doi.org/10.1111/dar.13282

Gibbs D; Price O; Grebely J; Larney S; Sutherland R; Read P; Butler K; Degenhardt L; Peacock A, 2021, 'Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109050

Curtis M; Larney S; Higgs P; Cossar RD; Winter RJ; Stewart AC; Stoové M, 2021, 'Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy', Journal of Addiction Medicine, 15, pp. 525 - 526, http://dx.doi.org/10.1097/ADM.0000000000000788

Bharat C; Larney S; Barbieri S; Dobbins T; Jones NR; Hickman M; Gisev N; Ali R; Degenhardt L, 2021, 'The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study', Addiction, 116, pp. 3139 - 3152, http://dx.doi.org/10.1111/add.15514

Bharat C; Degenhardt L; Dobbins T; Larney S; Farrell M; Barbieri S, 2021, 'Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109091

Back to profile page